# The Pulmonary Protection Trial

> **NCT01614951** · PHASE4 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 90 (actual)

## Conditions studied

- Chronic Obstructive Lung Disease

## Interventions

- **PROCEDURE:** Perfusion of the lungs
- **DRUG:** HTK Custodiol
- **OTHER:** Standard ECC

## Key facts

- **NCT ID:** NCT01614951
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2014-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01614951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01614951, "The Pulmonary Protection Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01614951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*